基石药业-B今日盘中大跌5.90%，引起了市场的广泛关注。
消息面上，公司此前根据配售协议以每股8.97港元的价格配发及发行1.18亿股新股，占配发前已发行股本约7.99%，总筹资约10.53亿港元。此外，公司于4月23日通过受限制股份奖励计划再发行600万股新股。短期内大规模新股发行导致股本从约14.76亿股扩大至约16亿股，股权稀释压力显著，叠加配售价较当前股价存在折价，市场抛压持续释放。
基石药业-B今日盘中大跌5.90%，引起了市场的广泛关注。
消息面上，公司此前根据配售协议以每股8.97港元的价格配发及发行1.18亿股新股，占配发前已发行股本约7.99%，总筹资约10.53亿港元。此外，公司于4月23日通过受限制股份奖励计划再发行600万股新股。短期内大规模新股发行导致股本从约14.76亿股扩大至约16亿股，股权稀释压力显著，叠加配售价较当前股价存在折价，市场抛压持续释放。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.